logo
'I'm utterly lost': Patients' anger over doctors strike cancellations

'I'm utterly lost': Patients' anger over doctors strike cancellations

Yahoo5 days ago
The resident doctors strike in England has begun after a dispute over pay between the government and the British Medical Association (BMA).
Thousands of doctors are walking out over five days, with Health Secretary Wes Streeting insisting that disruption will be kept to a minimum.
But several NHS patients have told the BBC they fear their conditions could become worse after delays to scheduled procedures, while some have also expressed sympathy over the concerns the doctors are raising.
Peter Plant, 58, of Tamworth, who has kidney cancer, said his surgery to remove the organ on Friday was cancelled on Thursday morning. The operation has been rescheduled for 20 August, but he fears the delay could be a "death sentence".
"Resident doctors do not care that delaying operations like mine are very likely a death sentence," he said.
"I'm absolutely angry and frustrated. It is not just about me, it's about our whole family.
"You try and gear yourself up for it and then it's utter deflation."
Mr Plant said he and his family had been living in "limbo" and that he felt "utterly lost".
"Wes Streeting says he has told hospitals to carry on as normal and they're clearly not," he added.
Official figures have not yet been released on the impact of the strike. Some hospitals are reporting more than 80% of their non-urgent work is still being carried out.
Previous walkouts have led to mass cancellations of operations, appointments and treatments: more than one million were cancelled during resident doctor strikes in March 2023 and routine care was cut by half at some hospitals.
'My three-year-old needs surgery now'
Hassnain Shahid, from Bradford, said his three-year-old daughter urgently needed lung surgery but it had been indefinitely postponed - despite medical warnings about the risks of delay.
"It's been an emotional rollercoaster and it's very frustrating for us," Mr Shahid said.
Mr Shahid's daughter has Congenital Pulmonary Airway Malformation (CPAM), a rare lung condition.
He said consultants told him surgery was urgent and that it was important it took place in the summer when there was less chance his daughter could catch a cold.
"Now we've been told the surgery has been cancelled and they have no availability - not even in September," he said.
"They were the ones that said she needed to have it done.
"I understand why the doctors are striking, but when you take this path and you go to university you know how much you're going to earn - if you're not happy with the pay, look at an alternative career."
Repeated delays to surgery
Sarah, a patient from the north-west of England, said she was due to have a hysterectomy - an operation to remove her uterus - on Monday but it had been cancelled for a second time.
"They don't have a rescheduled date for me at this time," she said. "It's very hard when you have been mentally preparing yourself for major surgery, especially as I was first told that I needed one in November 2024."
Andrew Mundy, 58, from Lincoln, expressed fears that repeated delays to his tendon surgery could leave him permanently injured.
He injured his knee in early February and was given an initial date for surgery at the end of May, which he said was cancelled because the consultant was on holiday.
The surgery was rearranged for Friday but was cancelled because of the strike, he said.
"I am furious and aware that every delay in surgery will make the chances of a successful repair even less likely," he said.
"It is not fair that I may never recover from this injury due to delays in treatment.
"It's frustrating because [the NHS] say that they are not cancelling stuff and things are running as normal, but they are cancelling stuff."
Michele, from Somerset, has been waiting three years for spinal surgery. She has been told her appointment, which had been scheduled for Thursday, has been cancelled, which she believes is down to the strikes.
Michele said she suffers "constant" and "relentless" nerve pain down the left side of her body.
"I feel I've been let down, I feel like I'm not worth it. It's knocked me," she said.
Michele said she had taken sick leave from work for more than a fortnight, having already taken a step back from her leadership role to work part-time from home due to the pain.
"It's got to the point so I can't even do that now. It's really affecting my life," she added.
John Dixon, 81, from the Isle of Wight, said he found out that his knee operation scheduled for Friday at Southampton General Hospital was cancelled with just three hours' notice.
Mr Dixon said he was already on the ferry to Southampton when he received a call from the hospital informing him of the cancellation.
"How can the NHS treat patients like this?" he said. "They must have [had] a good idea [on Thursday] without letting people go on long journeys just to return home."
Michael Overson, from Gainsborough, Lincolnshire, has been waiting three years for a knee operation and found out on Friday his surgery, which had been scheduled for Tuesday, had been cancelled.
Mr Overson is a delivery driver for a national supermarket chain and says the delay means he will have to "continue living and working in pain".
"This places me in limbo as I have no idea when it'll be rearranged. I can't plan anything," he said.
"The increased costs the strikes cause only causes greater harm to the NHS."
Dr Tom Dolphin, the chairman of the BMA, said before the action began that "we are very sorry that strikes have become necessary".
"Of course if people have emergencies or need urgent care they should still present to the hospital or their GP as usual, as they always would," he said.
"Striking is something that doctors don't want to have to do."
Additional reporting by Bernadette McCague, Mary Litchfield, Rozina Sini and Kris Bramwell
NHS faces challenging few days during doctors strike, warns Streeting
Why are resident doctors striking and what are they paid?
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Honey-Sweetened ‘Ice Cream For Bears' Is The Poster Child For Clean Ingredients
Honey-Sweetened ‘Ice Cream For Bears' Is The Poster Child For Clean Ingredients

Forbes

time42 minutes ago

  • Forbes

Honey-Sweetened ‘Ice Cream For Bears' Is The Poster Child For Clean Ingredients

Tim Berg is a simple guy. He likes eating fresh foods and spending time outdoors. Ice Cream for Bears is Berg's experiment to prove that nature's bare gifts are beyond plentiful to satisfy our cravings. After two years in the wilderness, Ice Cream for Bears is entering thousands of stores, including Kroger banner stores, and rolling out a panoply of grizzly flavors. 'It makes me sad when people think they can't have things that are delicious because they're trying to be healthy,' Berg tells me. 'Everything behind the Ice Cream for Bears brand is to try and eat things in the form closest to which they were eaten ten thousand years ago.' Raw, Unfiltered Honey And Pasture-Raised Dairy As any wild bear would, Ice Cream for Bears strictly sources raw and unfiltered honey as its sole sweetener. The honey never gets heated to extreme temperatures in order to maintain its natural properties. 'You have this substitute in nature that is just as potent, if not more, than those other sweeteners,' Berg says. 'It's a rare moment where nature has the answer in spades to what's been processed.' Just like watermelon's peak in the summer and squash's in autumn, honey is also seasonal and takes on the characteristics of its geography. So as opposed to overly-standardized honey, customers may notice slight changes in taste when eating Ice Cream for Bears depending on the time of year. The mild honey blend is sourced from parts of Europe and South America. The processing, as opposed to any ultra-processing, simply filters out beeswax and other contaminants. 'All of our honey is tested to confirm origin, tested for foreign sugar contamination, tested to confirm enzyme activity is high and has not been degraded by heat,' Berg says. Honey is rare to find as a sweetener in ice cream, largely because it's a more expensive sweetener and its water content can make it difficult to work with. But once perfected, it can be the secret strategy for a velvety consistency. 'Honey is an antifreeze,' Berg explains. '[Our ice cream] has a softness to it…that is all honey.' In terms of its dairy, Berg wouldn't compromise on sourcing grass-fed. 'Thats what cows are supposed to be eating,' he says. He found reliable partners in Working Cows Dairy in Slocomb, Alabama. The organic farm, which is also Certified Grassfed by A Greener World, provides a custom dairy blend with a high milkfat percentage to Ice Cream for Bears. 'We're not making this for anybody else,' says Jonny de Jong, whose family owns and operates Working Cows Dairy, which also performs all of the dairy processing on the estate. '[Ice Cream for Bears is] trying to be different and simple and that is a challenge, but also creates a remarkable product.' Working Cows Dairy is working towards gaining a certification for its regenerative agriculture practices. As a farm with high animal welfare and grazing standards, these cattle have constant access to pasture. Rotational grazing on the farm allows the grass' roots to keep growing once it's eaten to help maintain a strong root structure, and in return, healthy soil. '[Berg] understands that we're going to face challenges working with nature,' de Jong says. 'They're supporting us as a local farm, so that means a lot to us down here.' Other than dairy and honey, the only ingredient in the base of Ice Cream for Bears is egg, which makes it a French ice cream. Other ingredients for individual flavors include extracts like vanilla or orange for the Roar-ange Cream flavor, cacao nibs for Chocturnal, coffee for Bearista and vanilla bean for Queen & Bean. This fall, Ice Cream for Bears will add three new flavors to its lineup: Dough Bear (cookie dough made from dates), Churro and Burrow (cinnamon) and Cubbies & Cream (cookies & cream). 'As we grow,' Berg says, 'I want our sourcing, our supply chain to get even better.' Scoop School Berg has always had an affinity for the outdoors and connecting with nature, which has inspired his personal diet of minimal processed foods. But still, he would battle his sweet tooth. 'I was looking for something sweet and delicious that would fill this sort-of ancestral criteria that I formed for myself in my way of eating,' he says. Ice Cream for Bears began with a flimsy ice cream maker while Berg earned a Master's in entrepreneurship at Washington University in St. Louis, before a pitch competition changed its trajectory. 'This guy–Steve Christensen, one of my favorite people in the world–was invited to be a judge,' Berg says. 'He owns this place in St. Louis called Scoop School.' Berg finally got his hands on some commercial equipment when Christensen invited him to Scoop School, which teaches the tricks and trades of opening an ice cream shop. The moment he graduated, Berg sold his first pint of Ice Cream for Bears, beginning with farmers markets in St. Louis, graduating to some local shops. A proud moment was when he was able to upgrade his ice cream maker to a Musso Lussino. Ice Cream for Bears is now made with a co-manufacturer in Wisconsin. In early 2024, about two years later, Ice Cream for Bears landed its first major account with Sprouts Farmers Market. Ice Cream For Everyone 'It was a wild couple of months,' Berg says about raising money to ramp up production for more than 400 Sprouts stores nationwide. He was still running just on the $8,000 he invested from his own bank account. Ice Cream for Bears is now a permanent staple in Sprouts' ice cream set. By the end of 2025, Ice Cream for Bears will be in nearly 5,000 stores nationwide. That's not just natural grocers like Sprouts and Fresh Thyme Market, but conventional ones like Raley's and Kroger. Landing on a price point of $7.99, Berg was willing to sacrifice a couple of dollars per pint so that most anyone could access a clean yet awesomely delicious ice cream. 'Velocity has really helped us survive on lower margins,' Berg says. The provocative name helps drive those velocities, making shoppers do a double-take when browsing for ice cream. The simplicity of the name reflects the simplicity of what's inside and masterfully explains the type of sweetener used. It also leaves an opening for future line extensions, like Hot Fudge for Bears, which will debut soon. Ice Cream for Bears' Creative and Marketing Director Tara Berg led the branding effort. 'The logo itself is very cartoony and friendly and fun,' she says. Tara, who also happens to be Berg's sister, has created an entire universe of two-dimensional bears in a range of scenarios where it would be slobbering down honey. 'It's always a marriage of this serious and cool nature imagery, but we make it a little more whimsical.' That whimsical feeling correlates with the brand's more blunt tone about ingredients used in our food system. 'We are not afraid to call out the things we don't like in the food industry', Tara says. 'We try to be transparent and authentic and give people a peek behind the curtain because we're really proud of everything we do and how we source,' she continues. 'We want other companies to try to do the same.' Berg simply wants his product to be an example of what our food system should look like. 'This value system that I feel so strongly about has helped me in my own life, and I can share it with people through this product that isn't asking them to sacrifice anything,' he says. 'Everything going into this product is fit for a bear, this icon of the wilderness.' As the brand likes to say, the future of food is in the past.

Should You be Confident in Argenx SE (ARGX)?
Should You be Confident in Argenx SE (ARGX)?

Yahoo

timean hour ago

  • Yahoo

Should You be Confident in Argenx SE (ARGX)?

Baron Funds, an investment management company, released its 'Baron Health Care Fund' second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund declined 5.06% (Institutional Shares) in the quarter, against a challenging backdrop for the broader Health Care sector, compared to a 6.19% decline for the Russell 3000 Health Care Index (benchmark) and a 10.99% gain for the Russell 3000 Index (the Index). In addition, please check the fund's top five holdings to know its best picks in 2025. In its second-quarter 2025 investor letter, Baron Health Care Fund highlighted stocks such as Argenx SE (NASDAQ:ARGX). Argenx SE (NASDAQ:ARGX) designs and manufactures electrical, electronic, and fiber optic connectors. The one-month return of Argenx SE (NASDAQ:ARGX) was 10.20%, and its shares gained 16.02% of their value over the last 52 weeks. On July 30, 2025, Argenx SE (NASDAQ:ARGX) stock closed at $598.89 per share, with a market capitalization of $36.652 billion. Baron Health Care Fund stated the following regarding Argenx SE (NASDAQ:ARGX) in its second quarter 2025 investor letter: "Argenx SE (NASDAQ:ARGX is a biotechnology company best known for developing Vyvgart, the leading FcRn inhibitor for the treatment of autoimmune conditions. Shares declined after Q1 Vyvgart sales came in below elevated investor expectations due to a combination of seasonal factors (such as insurance reverification) and higher Medicare Part D utilization and associated discounts. Our conversations with management and neurologists continue to reinforce Vyvgart's value as an important treatment option with strong long-term growth potential. The drug continues to launch well in both generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy. Over time, we expect Vyvgart to demonstrate efficacy across an expanding range of autoantibody-driven autoimmune conditions, supported by encouraging Phase 2 myositis data recently presented by argenx at a major medical conference." A lab setting filled with scientific equipment and researchers in lab coats working together to develop new therapies for autoimmune diseases. Argenx SE (NASDAQ:ARGX) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 54 hedge fund portfolios held Argenx SE (NASDAQ:ARGX) at the end of the first quarter, which was 47 in the previous quarter. While we acknowledge the potential of Argenx SE (NASDAQ:ARGX) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered Argenx SE (NASDAQ:ARGX) and shared the list of high growth stocks outside tech analysts are bullish on. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Risankizumab Maintains Long-Term Effectiveness in Psoriasis
Risankizumab Maintains Long-Term Effectiveness in Psoriasis

Medscape

timean hour ago

  • Medscape

Risankizumab Maintains Long-Term Effectiveness in Psoriasis

TOPLINE: Risankizumab was well tolerated and demonstrated sustained effectiveness and drug survival in patients with moderate-to-severe psoriasis over a period of 4 years. Obesity, difficult-to-treat sites, and prior biologic use delayed the response, whereas bio-naive patients had faster first-year outcomes. METHODOLOGY: Researchers conducted an observational retrospective study of patients with moderate-to-severe psoriasis, with or without psoriatic arthritis, at the Turin University Hospital between 2020 and 2024. A total of 545 adult participants (mean age at psoriasis onset, 33.3 years; 60.1% men) received risankizumab 150 mg at weeks 0 and 4 and then every 12 weeks subsequently. Study outcomes were the achievement of Psoriasis Area and Severity Index (PASI) 100 and PASI 90 at various timepoints between weeks 16 and 208. Drug survival, defined as the time from initiation to discontinuation, was evaluated alongside predictors of response to risankizumab including obesity, bio-naive status, and difficult-to-treat sites. TAKEAWAY: The mean PASI score decreased significantly from 14 at baseline to 0.4 at week 208. PASI 100 responses increased from 33% at week 16 to 74% at week 208, and PASI 90 responses increased from 47% to 85% over the same period. Bio-naive patients achieved PASI 100 more often than bio-experienced patients at week 16 (38% vs 27%; P = .025), week 28 (63% vs 44%; P < .001), and week 52 (73% vs 57%; P = .002); similar trends were seen for PASI 90. Similarly, patients without obesity were significantly more likely than those with obesity to achieve PASI 100 (66% vs 55%; P = .029) and PASI 90 (78% vs 63%; P = .012) at week 52. Drug survival was notably high at 87.2% for the observed cases after week 208. The presence of a difficult-to-treat site significantly reduced the risk for interruption (hazard ratio, 0.15; P < .001). Overall, 11.6% of patients discontinued the treatment, with the leading cause being secondary failure (38.1%), and adverse events prompted discontinuation in 13 patients. IN PRACTICE: "Risankizumab showed excellent effectiveness, safety, and DS [drug survival] over 4 years of treatment," the authors wrote. "Obesity and involvement of a difficult-to-treat area can lower the initial response, even if they did not affect treatment interruption," they concluded, observing that "bio-naïve patients benefit from a faster response during the first year of treatment." SOURCE: This study was led by Luca Mastorino, Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy. It was published online on July 23, 2025, in Clinical and Experimental Dermatology. LIMITATIONS: The analysis of observed cases and those lost to follow-up weakened the 4-year survival estimate, showcasing an inherent limitation of real-world studies. Additionally, this study could not differentiate effectiveness on the basis of different difficult-to-treat sites. DISCLOSURES: This study did not receive any specific grant from any funding agency in the public, commercial, or not-for-profit sectors. The authors declared having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store